Clinical Trial Update: Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing perifosine with bortezomib with or without dexamethasone in multiple myeloma; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Multiple Myeloma, Multiple Myeloma in Relapse | Phase 1, Phase 2 | Status: COMPLETED